Insider trades › Verizon › Kyle Malady
Kyle Malady: Verizon stock transactions
Kyle Malady (EVP and Group CEO-VZ Business at Verizon) reported 8 transactions in VZ stock on SEC Form 4 over the last 120 days. Name as filed with the SEC: Malady Kyle.
$429Kopen-market sales (8,800 shares)
$0open-market purchases (0 shares)
2026-10-06most recent transaction
Transactions
| Date | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| Oct 6, 2026 | Open-market sale 10b5-1 plan | 1,100 | $45.75 | $50K | Form 4 ↗ |
| Sep 29, 2026 | Open-market sale 10b5-1 plan | 1,100 | $46.40 | $51K | Form 4 ↗ |
| Sep 22, 2026 | Open-market sale 10b5-1 plan | 1,100 | $47.65 | $52K | Form 4 ↗ |
| Sep 15, 2026 | Open-market sale 10b5-1 plan | 1,100 | $51.19 | $56K | Form 4 ↗ |
| Sep 8, 2026 | Open-market sale 10b5-1 plan | 1,100 | $49.98 | $55K | Form 4 ↗ |
| Sep 1, 2026 | Open-market sale 10b5-1 plan | 1,100 | $50.50 | $56K | Form 4 ↗ |
| Aug 25, 2026 | Open-market sale 10b5-1 plan | 1,100 | $50.06 | $55K | Form 4 ↗ |
| Aug 18, 2026 | Open-market sale 10b5-1 plan | 1,100 | $48.68 | $54K | Form 4 ↗ |
Source: SEC EDGAR Form 4 filings; each row links to the filing. Sales marked "10b5-1 plan" were reported as made under a pre-arranged trading plan. Insider trades are reported facts, not recommendations. Not investment advice.